Literature DB >> 14564177

Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.

Martha Wadleigh1, Vincent Ho, Parisa Momtaz, Paul Richardson.   

Abstract

Hepatic veno-occlusive disease (VOD) is one of the most serious complications following hematopoietic stem cell transplantation (SCT) and is associated with a very high mortality in its severe form. This review outlines the pathogenesis and clinical features of VOD, with an emphasis on endothelial cell injury and risk factors. The current status and future directions of research for both prophylaxis and treatment are also discussed.

Entities:  

Mesh：

Year:  2003        PMID： 14564177     DOI： 10.1097/00062752-200311000-00010

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN： 1065-6251            Impact factor:   3.284


  24 in total

Review 1.  Hepatic radiation toxicity: avoidance and amelioration.

Authors:  Chandan Guha; Brian D Kavanagh
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

Review 2.  [Thrombophilic states in intensive care medicine].

Authors:  L Engelmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-28       Impact factor: 0.840

3.  Escalation to High-Dose Defibrotide in Patients with Hepatic Veno-Occlusive Disease.

Authors:  Brandon M Triplett; Hani I Kuttab; Guolian Kang; Wing Leung
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-14       Impact factor: 5.742

4.  Acute hepatic dysfunction with abdominal pain and ascites.

Authors:  Aamer Agha; Norman Sussman
Journal:  MedGenMed       Date:  2007-05-09

5.  Veno-occlusive disease following high dose melphalan.

Authors:  Tuphan Kanti Dolai; K S Nataraj; Maitreyee Bhattacharya; Malay Kumar Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2011-08-18       Impact factor: 0.900

6.  Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalan.

Authors:  Sana Intidhar Labidi; Catherine Sebban; Hervé Ghesquières; Emmanuele Virelizier Nicolas; Pierre Biron
Journal:  Int J Hematol       Date:  2008-08-12       Impact factor: 2.490

Review 7.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

Authors:  Jason A Coppell; Paul G Richardson; Robert Soiffer; Paul L Martin; Nancy A Kernan; Allen Chen; Eva Guinan; Georgia Vogelsang; Amrita Krishnan; Sergio Giralt; Carolyn Revta; Nicole A Carreau; Massimo Iacobelli; Enric Carreras; Tapani Ruutu; Tiziano Barbui; Joseph H Antin; Dietger Niederwieser
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-18       Impact factor: 5.742

8.  Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1.

Authors:  Islam R Younis; Meenal Elliott; Cody J Peer; Arthur J L Cooper; John T Pinto; Gregory W Konat; Michal Kraszpulski; William P Petros; Patrick S Callery
Journal:  J Pharmacol Exp Ther       Date:  2008-09-12       Impact factor: 4.030

Review 9.  Radiological and histopathological manifestations of hepatocellular nodular lesions concomitant with various congenital and acquired hepatic hemodynamic abnormalities.

Authors:  Satoshi Kobayashi; Osamu Matsui; Toshifumi Gabata; Junichiro Sanada; Wataru Koda; Tetsuya Minami; Yasuji Ryu
Journal:  Jpn J Radiol       Date:  2009-03-12       Impact factor: 2.374

10.  Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.

Authors:  Constantine S Mitsiades; Cecile Rouleau; Cinara Echart; Krishna Menon; Beverly Teicher; Maria Distaso; Antonio Palumbo; Mario Boccadoro; Kenneth C Anderson; Massimo Iacobelli; Paul G Richardson
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.